NCT06008210Completed
A Decision Aid on End-of-life Care for Patients With Advanced COPD and Their Family
Effects of a Decision Support Intervention on End-of-life Care Planning in Patients With Advanced Chronic Obstructive Pulmonary Disease and Their Family Members: A Mixed Method Approach
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
This study aims to support EOL decision-making in patients with advanced COPD and their family members. A parallel two-arm single-blinded randomised controlled trial will be conducted to evaluate the effects of a specific decision support intervention. A total of 226 patients with advanced COPD and their designated family members will be recruited from hospital wards and outpatient clinics.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 226 (actual)
- First submitted
- 18 Aug 2023
- Start date
- 1 Sept 2023
- Primary completion date
- 3 Aug 2025
- Lead sponsor
- Food and Health Bureau, Hong Kong
- Diseases
- COPD
- NCT number
- NCT06008210
What you commit to
- Study type: Interventional
- Participants enrolled: 226
- From 1 Sept 2023 to the primary completion date, 3 Aug 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- are receiving palliative care services or
Other illness
- non-communicable due to a severe hearing impairment, dysphasia or a language barrier;
Other
- have already completed ACP or an advance directive.
Who the study is looking for
- are aged 50 years or over
- have been diagnosed with COPD
- are cognitively sound (scored \> 5 on the validated Abbreviated Mental Test (Hong Kong version) \[AMT-HK\])
- meet at least two of the six specific clinical indicators related to advanced COPD in the Gold Standards Framework (GSF) Proactive Identification Guidance, 6th Edition
- can nominate a family member who would take part in their healthcare decision- making.
- are aged 18 years or over,
- can communicate in Cantonese,
- have at least one personal contact per week with the patient in the past 6 months and
- are willing to join the study. Family members will be excluded if they score \< 6 on the AMT-HK or are expecting to leave Hong Kong within the next 6 months.
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tai Po Hospital Coordinator of this site? Confirm its status | Hong Kong | China | Unknown status |
| Prince of Wales Hospital Coordinator of this site? Confirm its status | Hong Kong | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.